Open AccessA Dose‐Escalation Safety and Immunogenicity Study of Live Attenuated Oral Rotavirus Vaccine 116E in Infants: A Randomized, Double‐Blind, Placebo‐Controlled Trial
Author(s) -
Nita Bhandari,
Pooja Sharma,
Sunita Taneja,
Tivendra Kumar,
Temsunaro RongsenChandola,
Mohan Babu Appaiahgari,
Arpita Mishra,
Shakti Singh,
Sudhanshu Vrati
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/600104
Subject(s) - medicine , placebo , rotavirus vaccine , adverse effect , rotavirus , vaccination , clinical trial , immunogenicity , pediatrics , immunology , diarrhea , immune system , alternative medicine , pathology
Rotavirus infections cause approximately 122,000 deaths among Indian children annually.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom